Stephana Patton
General Counsel bei CUTERA, INC.
Vermögen: 163 200 $ am 30.04.2024
Profil
Dr. Stephana E.
Patton is a Chief Legal Officer at Cutera, Inc. Dr. Patton was previously employed as a Secretary & Chief Compliance Officer by Eiger BioPharmaceuticals, Inc., a Secretary, Compliance Officer & General Counsel by BioTime, Inc., a Compliance Officer & General Counsel by BioDelivery Sciences International, Inc., a Head-Intellectual Property & Licensing by Salix Pharmaceuticals Ltd., and a Chief Legal Officer by Venn Biosciences Corp.
She received her graduate degree from Boston University School of Law and a doctorate degree from Emory University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CUTERA, INC.
0,40% | 06.03.2024 | 80 000 ( 0,40% ) | 163 200 $ | 30.04.2024 |
| 13.05.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Stephana Patton
| Unternehmen | Position | Beginn |
|---|---|---|
| CUTERA, INC. | General Counsel | 13.11.2023 |
Ehemalige bekannte Positionen von Stephana Patton
| Unternehmen | Position | Ende |
|---|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Compliance Officer | 09.04.2021 |
| LINEAGE CELL THERAPEUTICS, INC. | Compliance Officer | 01.03.2019 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Compliance Officer | 01.02.2017 |
| SALIX PHARMACEUTICALS, LTD. | Corporate Officer/Principal | 01.06.2015 |
Venn Biosciences Corp.
 Venn Biosciences Corp. BiotechnologyHealth Technology Venn Biosciences Corp. engages in developing an artificial intelligence-driven mass spectrometry discovery and validation platform. Its products include VENN Vista, a glycoproteomic analysis; OpenPIP software, a neural network for automated mass spectrometry peak integration; and cancer liquid biopsy. The company was founded by Lieza Denan, Aldo Carrascoso, Carlito B. Lebrilla, and Carolyn R. Bertozzi in June 2017 and is headquartered in South San Francisco, CA. | General Counsel | - |
Ausbildung von Stephana Patton
| Boston University School of Law | Graduate Degree |
| Emory University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| LINEAGE CELL THERAPEUTICS, INC. | Health Technology |
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| CUTERA, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Salix Pharmaceuticals Ltd.
 Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Salix Pharmaceuticals Ltd. develops and commercializes prescription drugs and medical devices used in the treatment of gastrointestinal diseases, endocrinology, hepatology, colorectal surgery, and internal medicine. It offers Anusol, Apriso, Colazal, Deflux, Diuril, Fenoglide, MoviPrep, Pepcid, Solesta, and Zegerid. The company was founded by randy W. Hamilton and Lorin K. Johnson in1989 and is headquartered in Bridgewater, NJ. | Health Technology |
Venn Biosciences Corp.
Venn Biosciences Corp. BiotechnologyHealth Technology Venn Biosciences Corp. engages in developing an artificial intelligence-driven mass spectrometry discovery and validation platform. Its products include VENN Vista, a glycoproteomic analysis; OpenPIP software, a neural network for automated mass spectrometry peak integration; and cancer liquid biopsy. The company was founded by Lieza Denan, Aldo Carrascoso, Carlito B. Lebrilla, and Carolyn R. Bertozzi in June 2017 and is headquartered in South San Francisco, CA. | Health Technology |
